Increased periostin, alongside other biomarkers, correlates with distal tubular damage and enhances diagnostic precision for diabetic nephropathy.
Combining biomarkers like periostin, NGAL, and KIM-1 may improve diagnostic precision for assessing tubulointerstitial damage in diabetic nephropathy.
Absolute Event Rate: 0% vs 0%
This article comments on Varatharajan et al recent article, highlighting the role of tubulointerstitial damage mechanisms in diabetic nephropathy progression. Evidence suggests a bidirectional interaction between the interstitium, tubular cells, and glomeruli. Renal tubules are highly susceptible to proteinuria, metabolic disorders, and toxins. Since diabetic nephropathy persistently activates inflammatory and fibrotic pathways, epithelial-to-mesenchymal transition mechanisms present promising targets for risk assessment. Periostin, a cellular matrix protein, plays a key role in modulating extracellular interactions. Increased periostin expression in tissue, serum, and urine correlates with type 2 diabetes, making it a valuable biomarker alongside neutrophil gelatinase-associated lipocalin and kidney injury molecule-1. While periostin and neutrophil gelatinase-associated lipocalin reflect distal tubular damage, kidney injury molecule-1 serves as a marker for proximal tubular injury. Combining these biomarkers enhances diagnostic precision.
Alamilla-Sanchez et al. (Mon,) reported a other. Increased periostin, alongside other biomarkers, correlates with distal tubular damage and enhances diagnostic precision for diabetic nephropathy.